HEADER SIGNALING PROTEIN 07-JUN-18 6GQP TITLE CRYSTAL STRUCTURE OF HUMAN KDR (VEGFR2) KINASE DOMAIN IN COMPLEX WITH TITLE 2 AZD3229-ANALOGUE (COMPOUND 23) COMPND MOL_ID: 1; COMPND 2 MOLECULE: VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: VEGFR-2,FETAL LIVER KINASE 1,FLK-1,KINASE INSERT DOMAIN COMPND 5 RECEPTOR,KDR,PROTEIN-TYROSINE KINASE RECEPTOR FLK-1; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES; COMPND 8 OTHER_DETAILS: HUMAN KDR KINASE DOMAIN D807-D1171 WITH AN INTERNAL COMPND 9 DELETION OF T940-E990, REPLACED BY A SINGLE VALINE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KDR, FLK1, VEGFR2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF21 KEYWDS RECEPTOR TYROSINE KINASE, INHIBITOR, ONCOLOGY, GASTROINTESTINAL KEYWDS 2 STROMAL TUMOUR, STRUCTURE-BASED DRUG DESIGN, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR C.J.HARDY,M.SCHIMPL,D.J.OGG,R.C.OVERMAN,M.J.PACKER,J.G.KETTLE, AUTHOR 2 R.ANJUM,E.BARRY,D.BHAVSAR,C.BROWN,A.CAMPBELL,K.GOLDBERG,M.GRONDINE, AUTHOR 3 S.GUICHARD,T.HUNT,O.JONES,X.LI,O.MOLEVA,S.PEARSON,W.SHAO,A.SMITH, AUTHOR 4 J.SMITH,D.STEAD,S.STOKES,M.TUCKER,Y.YE REVDAT 4 17-JAN-24 6GQP 1 REMARK REVDAT 3 31-OCT-18 6GQP 1 JRNL REVDAT 2 03-OCT-18 6GQP 1 JRNL REVDAT 1 19-SEP-18 6GQP 0 JRNL AUTH J.G.KETTLE,R.ANJUM,E.BARRY,D.BHAVSAR,C.BROWN,S.BOYD, JRNL AUTH 2 A.CAMPBELL,K.GOLDBERG,M.GRONDINE,S.GUICHARD,C.J.HARDY, JRNL AUTH 3 T.HUNT,R.D.O.JONES,X.LI,O.MOLEVA,D.OGG,R.C.OVERMAN, JRNL AUTH 4 M.J.PACKER,S.PEARSON,M.SCHIMPL,W.SHAO,A.SMITH,J.M.SMITH, JRNL AUTH 5 D.STEAD,S.STOKES,M.TUCKER,Y.YE JRNL TITL DISCOVERY OF JRNL TITL 2 N-(4-{[5-FLUORO-7-(2-METHOXYETHOXY) JRNL TITL 3 QUINAZOLIN-4-YL]AMINO}PHENYL)-2-[4-(PROPAN-2-YL)-1 JRNL TITL 4 H-1,2,3-TRIAZOL-1-YL]ACETAMIDE (AZD3229), A POTENT PAN-KIT JRNL TITL 5 MUTANT INHIBITOR FOR THE TREATMENT OF GASTROINTESTINAL JRNL TITL 6 STROMAL TUMORS. JRNL REF J. MED. CHEM. V. 61 8797 2018 JRNL REFN ISSN 1520-4804 JRNL PMID 30204441 JRNL DOI 10.1021/ACS.JMEDCHEM.8B00938 REMARK 2 REMARK 2 RESOLUTION. 2.09 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.09 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 57.19 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 3 NUMBER OF REFLECTIONS : 19924 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.820 REMARK 3 FREE R VALUE TEST SET COUNT : 961 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.09 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.20 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.72 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2887 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2530 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2731 REMARK 3 BIN R VALUE (WORKING SET) : 0.2510 REMARK 3 BIN FREE R VALUE : 0.2900 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 156 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2386 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 32 REMARK 3 SOLVENT ATOMS : 72 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.27 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.99 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.04970 REMARK 3 B22 (A**2) : 4.18510 REMARK 3 B33 (A**2) : -5.23470 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.01200 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.280 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.205 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.171 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.211 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.175 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.946 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.930 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2499 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3382 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 875 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 50 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 364 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2499 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 309 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2581 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.96 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.08 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.67 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 21.5136 -0.5025 12.2711 REMARK 3 T TENSOR REMARK 3 T11: -0.2085 T22: -0.2721 REMARK 3 T33: -0.2167 T12: -0.0239 REMARK 3 T13: 0.0266 T23: 0.0114 REMARK 3 L TENSOR REMARK 3 L11: 1.8346 L22: 1.9632 REMARK 3 L33: 2.1799 L12: -0.3094 REMARK 3 L13: 0.6029 L23: -0.5496 REMARK 3 S TENSOR REMARK 3 S11: 0.0139 S12: -0.1218 S13: -0.0117 REMARK 3 S21: 0.0840 S22: -0.0598 S23: -0.0753 REMARK 3 S31: -0.0698 S32: 0.2609 S33: 0.0458 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6GQP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-JUN-18. REMARK 100 THE DEPOSITION ID IS D_1200010417. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-NOV-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.92819 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27358 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.870 REMARK 200 RESOLUTION RANGE LOW (A) : 57.190 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.87 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.4 REMARK 200 DATA REDUNDANCY IN SHELL : 5.00 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 3WZD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.68 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 7 % PEG 8000, 0.1 M PCTP (SODIUM REMARK 280 PROPIONATE, SODIUM CACODYLATE TRIHYDRATE, BIS-TRIS PROPANE) PH REMARK 280 7.8, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 28.60000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15590 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 806 REMARK 465 ASP A 807 REMARK 465 PRO A 808 REMARK 465 ASP A 809 REMARK 465 GLU A 810 REMARK 465 LEU A 811 REMARK 465 PRO A 812 REMARK 465 LEU A 813 REMARK 465 ASP A 814 REMARK 465 GLU A 815 REMARK 465 HIS A 816 REMARK 465 CYS A 817 REMARK 465 GLU A 818 REMARK 465 ARG A 819 REMARK 465 LEU A 820 REMARK 465 GLN A 1169 REMARK 465 GLN A 1170 REMARK 465 ASP A 1171 REMARK 465 GLU A 1172 REMARK 465 ASN A 1173 REMARK 465 LEU A 1174 REMARK 465 TYR A 1175 REMARK 465 PHE A 1176 REMARK 465 GLN A 1177 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 943 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 826 -60.06 -93.76 REMARK 500 ALA A 844 -70.49 -90.26 REMARK 500 ARG A1027 -13.78 82.33 REMARK 500 ASP A1028 46.62 -141.60 REMARK 500 SER A1037 -168.96 -100.44 REMARK 500 ASP A1112 -156.71 -133.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue F88 A 1201 DBREF 6GQP A 806 1171 UNP P35968 VGFR2_HUMAN 806 1171 SEQADV 6GQP A UNP P35968 THR 940 DELETION SEQADV 6GQP A UNP P35968 LYS 941 DELETION SEQADV 6GQP A UNP P35968 GLY 942 DELETION SEQADV 6GQP A UNP P35968 ALA 943 DELETION SEQADV 6GQP A UNP P35968 ARG 944 DELETION SEQADV 6GQP A UNP P35968 PHE 945 DELETION SEQADV 6GQP A UNP P35968 ARG 946 DELETION SEQADV 6GQP A UNP P35968 GLN 947 DELETION SEQADV 6GQP A UNP P35968 GLY 948 DELETION SEQADV 6GQP A UNP P35968 LYS 949 DELETION SEQADV 6GQP A UNP P35968 ASP 950 DELETION SEQADV 6GQP A UNP P35968 TYR 951 DELETION SEQADV 6GQP A UNP P35968 VAL 952 DELETION SEQADV 6GQP A UNP P35968 GLY 953 DELETION SEQADV 6GQP A UNP P35968 ALA 954 DELETION SEQADV 6GQP A UNP P35968 ILE 955 DELETION SEQADV 6GQP A UNP P35968 PRO 956 DELETION SEQADV 6GQP A UNP P35968 VAL 957 DELETION SEQADV 6GQP A UNP P35968 ASP 958 DELETION SEQADV 6GQP A UNP P35968 LEU 959 DELETION SEQADV 6GQP A UNP P35968 LYS 960 DELETION SEQADV 6GQP A UNP P35968 ARG 961 DELETION SEQADV 6GQP A UNP P35968 ARG 962 DELETION SEQADV 6GQP A UNP P35968 LEU 963 DELETION SEQADV 6GQP A UNP P35968 ASP 964 DELETION SEQADV 6GQP A UNP P35968 SER 965 DELETION SEQADV 6GQP A UNP P35968 ILE 966 DELETION SEQADV 6GQP A UNP P35968 THR 967 DELETION SEQADV 6GQP A UNP P35968 SER 968 DELETION SEQADV 6GQP A UNP P35968 SER 969 DELETION SEQADV 6GQP A UNP P35968 GLN 970 DELETION SEQADV 6GQP A UNP P35968 SER 971 DELETION SEQADV 6GQP A UNP P35968 SER 972 DELETION SEQADV 6GQP A UNP P35968 ALA 973 DELETION SEQADV 6GQP A UNP P35968 SER 974 DELETION SEQADV 6GQP A UNP P35968 SER 975 DELETION SEQADV 6GQP A UNP P35968 GLY 976 DELETION SEQADV 6GQP A UNP P35968 PHE 977 DELETION SEQADV 6GQP A UNP P35968 VAL 978 DELETION SEQADV 6GQP A UNP P35968 GLU 979 DELETION SEQADV 6GQP A UNP P35968 GLU 980 DELETION SEQADV 6GQP A UNP P35968 LYS 981 DELETION SEQADV 6GQP A UNP P35968 SER 982 DELETION SEQADV 6GQP A UNP P35968 LEU 983 DELETION SEQADV 6GQP A UNP P35968 SER 984 DELETION SEQADV 6GQP A UNP P35968 ASP 985 DELETION SEQADV 6GQP A UNP P35968 VAL 986 DELETION SEQADV 6GQP A UNP P35968 GLU 987 DELETION SEQADV 6GQP A UNP P35968 GLU 988 DELETION SEQADV 6GQP A UNP P35968 GLU 989 DELETION SEQADV 6GQP VAL A 940 UNP P35968 GLU 990 CONFLICT SEQADV 6GQP GLU A 1172 UNP P35968 EXPRESSION TAG SEQADV 6GQP ASN A 1173 UNP P35968 EXPRESSION TAG SEQADV 6GQP LEU A 1174 UNP P35968 EXPRESSION TAG SEQADV 6GQP TYR A 1175 UNP P35968 EXPRESSION TAG SEQADV 6GQP PHE A 1176 UNP P35968 EXPRESSION TAG SEQADV 6GQP GLN A 1177 UNP P35968 EXPRESSION TAG SEQRES 1 A 322 MET ASP PRO ASP GLU LEU PRO LEU ASP GLU HIS CYS GLU SEQRES 2 A 322 ARG LEU PRO TYR ASP ALA SER LYS TRP GLU PHE PRO ARG SEQRES 3 A 322 ASP ARG LEU LYS LEU GLY LYS PRO LEU GLY ARG GLY ALA SEQRES 4 A 322 PHE GLY GLN VAL ILE GLU ALA ASP ALA PHE GLY ILE ASP SEQRES 5 A 322 LYS THR ALA THR CYS ARG THR VAL ALA VAL LYS MET LEU SEQRES 6 A 322 LYS GLU GLY ALA THR HIS SER GLU HIS ARG ALA LEU MET SEQRES 7 A 322 SER GLU LEU LYS ILE LEU ILE HIS ILE GLY HIS HIS LEU SEQRES 8 A 322 ASN VAL VAL ASN LEU LEU GLY ALA CYS THR LYS PRO GLY SEQRES 9 A 322 GLY PRO LEU MET VAL ILE VAL GLU PHE CYS LYS PHE GLY SEQRES 10 A 322 ASN LEU SER THR TYR LEU ARG SER LYS ARG ASN GLU PHE SEQRES 11 A 322 VAL PRO TYR LYS VAL ALA PRO GLU ASP LEU TYR LYS ASP SEQRES 12 A 322 PHE LEU THR LEU GLU HIS LEU ILE CYS TYR SER PHE GLN SEQRES 13 A 322 VAL ALA LYS GLY MET GLU PHE LEU ALA SER ARG LYS CYS SEQRES 14 A 322 ILE HIS ARG ASP LEU ALA ALA ARG ASN ILE LEU LEU SER SEQRES 15 A 322 GLU LYS ASN VAL VAL LYS ILE CYS ASP PHE GLY LEU ALA SEQRES 16 A 322 ARG ASP ILE TYR LYS ASP PRO ASP TYR VAL ARG LYS GLY SEQRES 17 A 322 ASP ALA ARG LEU PRO LEU LYS TRP MET ALA PRO GLU THR SEQRES 18 A 322 ILE PHE ASP ARG VAL TYR THR ILE GLN SER ASP VAL TRP SEQRES 19 A 322 SER PHE GLY VAL LEU LEU TRP GLU ILE PHE SER LEU GLY SEQRES 20 A 322 ALA SER PRO TYR PRO GLY VAL LYS ILE ASP GLU GLU PHE SEQRES 21 A 322 CYS ARG ARG LEU LYS GLU GLY THR ARG MET ARG ALA PRO SEQRES 22 A 322 ASP TYR THR THR PRO GLU MET TYR GLN THR MET LEU ASP SEQRES 23 A 322 CYS TRP HIS GLY GLU PRO SER GLN ARG PRO THR PHE SER SEQRES 24 A 322 GLU LEU VAL GLU HIS LEU GLY ASN LEU LEU GLN ALA ASN SEQRES 25 A 322 ALA GLN GLN ASP GLU ASN LEU TYR PHE GLN HET F88 A1201 32 HETNAM F88 ~{N}-[4-(6,7-DIMETHOXYQUINAZOLIN-4-YL)OXYPHENYL]-2-(1- HETNAM 2 F88 ETHYLPYRAZOL-4-YL)ETHANAMIDE FORMUL 2 F88 C23 H23 N5 O4 FORMUL 3 HOH *72(H2 O) HELIX 1 AA1 ASP A 823 GLU A 828 1 6 HELIX 2 AA2 PRO A 830 ASP A 832 5 3 HELIX 3 AA3 THR A 875 GLY A 893 1 19 HELIX 4 AA4 ASN A 923 LYS A 931 1 9 HELIX 5 AA5 PRO A 942 TYR A 946 5 5 HELIX 6 AA6 THR A 1001 ARG A 1022 1 22 HELIX 7 AA7 ALA A 1030 ARG A 1032 5 3 HELIX 8 AA8 GLU A 1038 ASN A 1040 5 3 HELIX 9 AA9 PHE A 1047 ARG A 1051 5 5 HELIX 10 AB1 PRO A 1068 MET A 1072 5 5 HELIX 11 AB2 ALA A 1073 ARG A 1080 1 8 HELIX 12 AB3 THR A 1083 PHE A 1099 1 17 HELIX 13 AB4 ASP A 1112 GLY A 1122 1 11 HELIX 14 AB5 THR A 1132 TRP A 1143 1 12 HELIX 15 AB6 GLU A 1146 ARG A 1150 5 5 HELIX 16 AB7 THR A 1152 ALA A 1168 1 17 SHEET 1 AA1 5 LEU A 834 LEU A 840 0 SHEET 2 AA1 5 GLY A 846 PHE A 854 -1 O VAL A 848 N LEU A 840 SHEET 3 AA1 5 CYS A 862 LEU A 870 -1 O VAL A 865 N ALA A 851 SHEET 4 AA1 5 MET A 913 GLU A 917 -1 O VAL A 914 N LYS A 868 SHEET 5 AA1 5 LEU A 901 CYS A 905 -1 N LEU A 902 O ILE A 915 SHEET 1 AA2 2 ILE A1034 LEU A1036 0 SHEET 2 AA2 2 VAL A1042 ILE A1044 -1 O LYS A1043 N LEU A1035 SHEET 1 AA3 2 VAL A1060 LYS A1062 0 SHEET 2 AA3 2 ALA A1065 LEU A1067 -1 O ALA A1065 N LYS A1062 CISPEP 1 ALA A 941 PRO A 942 0 5.10 SITE 1 AC1 15 LEU A 840 VAL A 848 ALA A 866 LYS A 868 SITE 2 AC1 15 GLU A 885 VAL A 899 VAL A 916 GLU A 917 SITE 3 AC1 15 CYS A 919 LEU A1035 CYS A1045 ASP A1046 SITE 4 AC1 15 HOH A1301 HOH A1329 HOH A1352 CRYST1 53.160 57.200 60.790 90.00 109.80 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018811 0.000000 0.006772 0.00000 SCALE2 0.000000 0.017483 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017484 0.00000